Bristol-Myers Squibb announced that Dr. Samit Hirawat will depart his role as Chief Medical Officer and Head of Development by November 1, 2025. He will transition to an advisory position effective August 1, 2025, and will receive severance benefits along with pro-rated equity and annual incentive payouts.
